1. Current literature highlights 1.1. Exploring chemical space around the privileged pyrazolo [3,4-d] 
pyrimidine scaffold
The pyrazolo [3,4-d] pyrimidine scaffold is found in a number of molecules with activity against biological targets including kinase inhibitors, antiviral agents, adenosine antagonists, glutamine modulators and anti-tubercular agents. The heterocyclic framework is isosteric to purine, and as such might be considered a 'privileged' structure for drug discovery. A recent publication describes an efficient route to the synthesis of a library of related pyrazolo [3,4-d] pyrimidines, and profiles their activity against a number of disease-relevant kinases [1] In particular, the synthetic approach was designed in a divergent fashion so as to permit the ready access to variously substituted pyrazolo [3,4-d] pyrimidines. The synthetic pathway permitted a sequential functionalisation of the C3 and C6 positions, and additional diversification of the N1 and C4 positions gave access to a range of useful 4-amino substituted pyrazolo [3,4-d] pyrimidines (1) that were screened against a number of tyrosine kinases implicated in the development and progression of tumours.
The synthesis commenced with the inexpensive and readily available thiobarbituric acid (2) , which in the first step was alkylated with methyl iodide under aqueous conditions using potassium hydroxide as base. The methylthiobarbituric acid was then subjected to Vilsmeier reaction conditions followed by cyclisation with hydrazine hydrate to give the intermediate C6 methylthio-pyrazolo [3,4-d] pyrimidines (3) . Alternatively, methylthiobarbituric acid could be treated with phosphorus oxychloride, C3-functionalised with benzaldehyde and cyclised with hydrazine hydrate to generate the C3 unsubstituted methylthio-pyrazolo [3,4-d] pyrimidines (4) . These two heterocyclic intermediates thus provided the substrates for further derivitisation. In each case alkylation under Mitsunobu conditions introduced sidechains onto the N1 position (5 and 6) . Amines could be introduced onto the C4 position by nucleophilic aromatic substitution of the chloride, and oxidation of the methylthio group to a mixture of sulphoxides and sulphones, provided leaving groups that could be replaced with amine nucleophiles to diversify the C6 position (7 and 8) . An alternative diversification strategy allowed for hydrogenolysis of the methylthio groups to generate compounds unsubstituted in the C6 position (9 and 10) .
Compounds generated in this library were screened for affinity against Src and both wild-type and T315I mutated forms of Abl kinases in cell free assays. Several revealed nanomolar inhibitory potency against these kinases, and interestingly, compound 11 inhibited mutated Abl with non-competitive kinetics with respect to ATP and the peptide substrate suggesting the presence of an allosteric inhibitory site on the kinase.
Overall this approach demonstrates an effective and diversityoriented approach to pyrazolo [3,4-d] pyrimidines useful as potential kinase inhibitors. 
Polymer supported synthesis
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Solution-phase synthesis
An efficient post-Ugi copper-catalysed intramolecular Ullmann coupling strategy has been elaborated for the diversity-oriented synthesis of 4H-benzo[f]imidazo [1, 4] diazepin-6-ones and the scope and limitations of this protocol have been investigated [2] .
A series of benzofuran-2-carboxamides of biological and medicinal significance have been synthesised by a microwaveassisted one-pot parallel approach via O-alkylation/Knoevenagel condensation. All products were characterised and assayed for their in vivo anti-inflammatory, analgesic and antipyretic activities. Activity data of all compounds have been listed; among which some derivatives exhibited potent activities of particular interest [3] .
A diversity-oriented method for the synthesis of novel poly-substituted pyrazolo [1,5-a] quinolines has been developed based on an SNAr/Knoevenagel cyclisation cascade reaction or an SNAr/Dieckmann-Thorpe cyclisation cascade reaction. The methods provided a variety of poly-substituted pyrazolo [1,5-a] quinolines bearing an amino, alkyl or aryl substituent at the 5-position. In addition, a diversity-oriented method for the synthesis of 2-substituted pyrazolo [1,5-a] quinolines from a readily available 2-[[(trifluoromethyl)sulphonyl]oxy]pyrazolo [1,5-a] quinoline was also disclosed [4] .
Scaffolds and synthons for combinatorial libraries
A convenient synthesis of four new enantiomerically pure acidic amino acids has been reported and their affinity at ionotropic glutamate receptors was determined. The new compounds are higher homologues of glutamic acid in which the molecular complexity has been increased by introducing an aromatic/heteroaromatic ring, that could give additional electronic interactions with the receptors. The synthetic route leading to this new class of ligands is fast, cheap and versatile, and a library of derivatives can be easily obtained by simply varying the nature of the aryl/heteroaryl halide [5] .
Bicyclic azetidin-3-ones with no acidic a-hydrogens, prepared in good yields via cis-2,4-di-O-triflates of pyranosides, are stable divergent intermediates for the synthesis of highly substituted azetidines. Preliminary studies on the reactions of bicyclic azetidinones indicate their potential as scaffolds for novel complex azetidines [6] .
Solid-phase supported reagents
A microwave assisted green protocol for the syntheses of triazole fused benzoxazines, benzoxazepines, quinoxalines, and benzothiazines has been reported using basic alumina as solid support. The one-pot reaction was carried out using Cu(phen)(PPh 3 )Br as a catalyst, and did not require the use of any additional ligands, base or the use of expensive and toxic palladium reagents [7] .
Preparation of PVC-supported Pd nanoparticles through the reduction of PdCl 2 by a non-toxic and eco-friendly route, employing sodium formate and NaOH in ethanol-water system has been described. The prepared PVC supported Pd nanoparticles were employed as a catalyst in cross coupling reactions such as Heck and Sonogashira using the aqueous medium to afford products in good to excellent yields [8] .
The solid phase synthesis of a poly(propylene imine) dendrimer has been described. An iterative synthesis including double Michael addition of acrylonitrile to the primary amino groups on crosslinked polystyrene support followed by reduction of nitrile groups to amino groups give poly(propylene imine) dendrimers up to third generation attached to the polystyrene support. The supported dendrimer has been used as an organocatalyst for Knoevenagel condensations. The supported catalyst showed good selectivity and the product was obtained in excellent yield under green reaction conditions, with the catalyst being recoverable and reusable [9] .
Novel resins, linkers and techniques
The NY-ESO-1 (A39-A68) peptide hydrazide has been prepared through 9-fluorenyl-methoxycarbonyl solid-phase peptide synthesis (Fmoc SPPS) from a new 9-fluorenyl-methoxycarbonyl hydrazine 2-chlorotrityl chloride (Fmoc-hydrazine 2CTC) resin. This new resin was ideal for long-term storage and usage in Fmoc SPPS, and the title peptide hydrazide could be transformed nearly quantitatively into the corresponding peptide thioester [10] .
The cleavage rates of various protecting groups from the exocyclic amine of cytosine, adenine, and guanine bases have been investigated. Specifically, deprotection of N-benzoyl (Bz), N-acetyl (Ac), N-isobutyryl (iBu), N-phenoxyacetyl (PAC) and N-tert-butylphenoxyacetyl (tBPAC) groups from 2'-deoxyribonucleosides was achieved under various cleavage conditions and the rates of cleavage (half-lives) determined. The results of this study permitted the mild and complete deprotection of an oligoribonucleotide while still attached to the solid support with a light labile linker, speeding up post-synthesis processing of the RNA chain and offering a new route to the synthesis of sensitive oligonucleotide derivatives on solid supports [11] .
Library applications
A series of 114 SIRT inhibitor candidates have been assembled into a library using 'click chemistry', by reacting two alkynes bearing a 2-anilinobenzamide pharmacophore with 57 azide building blocks in the presence of a copper (I) catalyst. Screening identified two SIRT2-selective inhibitors, which were more SIRT2-selective than AGK2, a known SIRT2 inhibitor. These findings will be useful in the further development of SIRT2-selective inhibitors [12] . The use of DNA-encoded library technology for the discovery of small molecules that are potent inhibitors of the interaction between lymphocyte function-associated antigen 1 and its ligand intercellular adhesion molecule 1 has been described. A library with a potential complexity of 4.1 billion compounds was exposed to the I-domain of the target protein and the bound ligands were affinity selected, yielding an enriched small-molecule hit family. Compounds representing this family were synthesised without their DNA encoding moiety and found to inhibit the lymphocyte function-associated antigen 1/intercellular adhesion molecule-1 interaction with submicromolar potency in both ELISA and cell adhesion assays [13] .
